Tango Therapeutics, INC. (TNGX) — 8-K Filings

All 8-K filings from Tango Therapeutics, INC.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

Tango Therapeutics Enters and Terminates Agreements — Nov 21, 2025 Risk: medium
Tango Therapeutics, Inc. entered into a material definitive agreement on November 18, 2025. The company also terminated a material definitive agreement on the s
Tango Therapeutics Files 8-K: Material Agreement & Equity Sales — Oct 24, 2025 Risk: medium
On October 23, 2025, Tango Therapeutics, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
Tango Therapeutics Files 8-K — Oct 23, 2025 Risk: low
Tango Therapeutics, Inc. filed an 8-K on October 23, 2025, reporting on its results of operations and financial condition, as well as other events and financial
Tango Therapeutics Announces CMO Departure, Director Changes — Aug 25, 2025 Risk: medium
Tango Therapeutics, Inc. announced on August 21, 2025, the departure of its Chief Medical Officer, Dr. Barbara N. Weber. The company also reported on compensato
Tango Therapeutics Files 8-K on Shareholder Votes and Bylaws — Jun 6, 2025 Risk: low
Tango Therapeutics, Inc. filed an 8-K on June 6, 2025, reporting on matters submitted to a vote of security holders and amendments to its articles of incorporat
8-K Filing — Jan 13, 2025
Tango Therapeutics Files 8-K on Shareholder Votes and Financials — Jun 6, 2024 Risk: low
Tango Therapeutics, Inc. filed an 8-K on June 6, 2024, reporting on matters submitted to a vote of security holders and financial statements. The company, forme
Gilead to Acquire Tango Therapeutics for $1.24B — May 23, 2024 Risk: medium
Tango Therapeutics, Inc. announced on May 23, 2024, that it has entered into a definitive agreement to be acquired by Gilead Sciences, Inc. for approximately $1
Tango Therapeutics Files 8-K for Financials — Mar 18, 2024 Risk: low
Tango Therapeutics, Inc. filed an 8-K on March 18, 2024, to report on its results of operations and financial condition, as well as to file financial statements
Tango Therapeutics Files 8-K on Financial Results — Feb 7, 2024
Tango Therapeutics, Inc. filed an 8-K on February 7, 2024, to announce its results of operations and financial condition. This filing, under Item 2.02, indicate

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX